CorConsult Rx: Evidence-Based Medicine and Pharmacy

Latest Episodes:

Pharmacologic Options for Chronic Pain *ACPE-Accredited* Dec 13, 2022

Show notes

On this episode, we discuss the various therapeutic options for managing a patient with chronic pain. We discuss nonpharmacological options, anti-inflammatory medications, and other non-opioid pharmacological options. Then, we compare and contrast some of the commonly used opioids and discuss some of the nuances/clinical pearls for individual opioids.

Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. To earn credit for this episode, visit the following link below to reach the post-activity test for this episode:

List of podcasts on freeCE.com

For existing Unlimited freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password PAIN (all caps) to unlock the post-test for this episode.

But if you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. CorConsult Rx listeners can save 15% off the purchase of an unlimited membership by entering the discount code "PODCAST2022" at checkout, or by clicking the following link:

https://hubs.ly/Q012N0H60

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com
Cole - cswanson@corconsultrx.com
AJ - aalford@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

Generalized Anxiety Disorder *ACPE-Accredited* Nov 28, 2022

Show notes

On this episode, Cole and I review the published treatment algorithm created by Harmony Raylen Abejuela, MD and David Osser, MD. This was part of the Psychopharmacology Algorithm Project at the Harvard South Shore Program. A link to the article on Pubmed is below:

Anxiety Algorithm

List of podcasts on freeCE.com

For existing Unlimited freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password WORRY (all caps) to unlock the post-test for this episode.

https://hubs.ly/Q012N0H60

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com AJ - aalford@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Our Thoughts on the Diuretic Comparison Project (DCP) Nov 21, 2022

Show notes

On this episode, we review the results that have been reported from the Diuretic Comparison Project (DCP). The point-of-care clinical trial was looking at CV outcomes based on patients using HCTZ vs chlorthalidone. We also discuss the reasons for using indapamide over other thiazide (like) diuretics.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Comparison of Oral Medications for Type-2 Diabetes *ACPE-Accredited* Nov 14, 2022

Show notes

On this episode, we compare and contrast oral medications that can be used to manage patients with type-2 diabetes. We review metformin, SGLT2 inhibitors, oral semaglutide, sulfonylureas, TZDs, and more.

Oral DM2 Meds

For existing Unlimited freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password DMMEDS (all caps) to unlock the post-test for this episode.

https://hubs.ly/Q012N0H60

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Updates in the Management of Amyotrophic Lateral Sclerosis Nov 11, 2022

Show notes

On this episode, we review the management of amyotrophic lateral sclerosis (ALS). We discuss riluzole, edaravone, and sodium phenylbutyrate-taurursodiol (Relyvrio) that gained FDA approval in September 2022.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Chronic Coronary Syndromes *ACPE-Accredited* Oct 31, 2022

Show notes

On this episode, we discuss chronic coronary syndromes, and we focus primarily on the treatment of acute episodes of angina.

Chronic Coronary Syndromes

For existing Unlimited freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password CORONARY (all caps) to unlock the post-test for this episode.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Managing Atrial Fibrillation *ACPE-Accredited* Oct 17, 2022

Show notes

On this episode, we discuss the management of acute and chronic atrial fibrillation. We review the various pharmacotherapy options, compare rate control versus rhythm control, and discuss other clinic trials that support the newest treatment guidelines.

Managing Atrial Fibrillation

For existing Unlimited freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password RHYTHM (all caps) to unlock the post-test for this episode.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

Celebrating Episode 200 with Dr. Wayne Weart Oct 16, 2022

Show notes

We are joined by Dr. Wayne Weart to celebrate reaching our 200th episode. We discuss his career as a clinical pharmacist and educator and get his thoughts on the current state of the pharmacotherapy world.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

SGLT-2 Inhibitors in Heart Failure *ACPE-Accredited* Oct 03, 2022

Show notes

On this episode, we review the data that lead to some SGLT-2 inhibitors being used routinely in heart failure. We discuss the initial cardiovascular safety studies that initially showed heart failure benefit in this class. Then we look as some of the newer studies that have looked at empagliflozin and dapagliflozin in heart failure patients (with and without diabetes as a comorbidity).

SGLT-2 Inhibitors in HF

For existing Unlimited freeCE members, this CE option is included in your membership benefits at no additional cost! Members can simply follow the link above to take the post-test and evaluation for this activity. Use the password NEWHF (all caps) to unlock the post-test for this episode.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

New Options for Managing Plaque Psoriasis Sep 27, 2022

Show notes

On this episode, we discuss deucravacitinib tablets (Sotyktu), roflumilast cream (Zoryve), and tapinarof cream (Vtama). All three medications were approved in 2022 and represent new classes of medication for the treatment of plaque psoriasis. We also give a brief overview of the older treatment options that are used for plaque psoriasis as well.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx